Article

Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring.

Brown University Department of Community Health, Providence, Rhode Island 02806, USA.
Biological psychiatry (Impact Factor: 9.47). 05/2008; 63(8):809-15. DOI: 10.1016/j.biopsych.2007.09.022
Source: PubMed

ABSTRACT Viral exposure during gestation is thought to be a risk factor for schizophrenia. Previous studies have indicated that prenatal exposure to herpes simplex virus type 2 (HSV-2) may be a risk for the subsequent development of schizophrenia in some populations. In this investigation, we tested a large and diverse population to assess the risk of psychoses among offspring of mothers with serological evidence of HSV-2 infection.
We conducted a nested case-control study of 200 adults with psychoses and 554 matched control subjects (matched for city and date of birth, race/ethnicity, gender, and parent history of treatment for mental disorder) from three cohorts of the Collaborative Perinatal Project (Boston, Providence, and Philadelphia). We analyzed stored serum samples that had been obtained from these mothers at the end of pregnancy for antibodies directed at HSV-2, using type-specific solid-phase enzyme immunoassay techniques.
Offspring of mothers with serologic evidence of HSV-2 infection were at significantly increased risk for the development of psychoses (odds ratio [OR] = 1.6; 95% confidence interval [CI] = 1.1-2.3). This risk was particularly elevated among women with high rates of sexual activity during pregnancy (OR = 2.6; 95% CI = 1.4-4.6).
Maternal exposure to herpes simplex virus type 2 is associated with an increased risk for psychoses among adult offspring. These results are consistent with a general model of risk resulting from enhanced maternal immune activation during pregnancy.

0 Followers
 · 
70 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiological studies have shown a clear association between maternal infection and schizophrenia or autism in the progeny. Animal models have revealed maternal immune activation (mIA) to be a profound risk factor for neurochemical and behavioural abnormalities in the offspring. Microglial priming has been proposed as a major consequence of mIA, and represents a critical link in a causal chain that leads to the wide spectrum of neuronal dysfunctions and behavioural phenotypes observed in the juvenile, adult or aged offspring. Such diversity of phenotypic outcomes in the mIA model are mirrored by recent clinical evidence suggesting that infectious exposure during pregnancy is also associated with epilepsy and, to a lesser extent, cerebral palsy in children. Preclinical research also suggests that mIA might precipitate the development of Alzheimer and Parkinson diseases. Here, we summarize and critically review the emerging evidence that mIA is a shared environmental risk factor across CNS disorders that varies as a function of interactions between genetic and additional environmental factors. We also review ongoing clinical trials targeting immune pathways affected by mIA that may play a part in disease manifestation. In addition, future directions and outstanding questions are discussed, including potential symptomatic, disease-modifying and preventive treatment strategies.
    Nature Reviews Neurology 10/2014; 10(11). DOI:10.1038/nrneurol.2014.187 · 14.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Los estudios previos han relacionado la exposición prenatal a la gripe con un mayor riesgo de padecer esquizofrenia; sin embargo, en ninguno se han examinado las secuelas del neurodesarrollo de esta agresión prenatal antes del inicio de los síntomas psicóticos con pruebas serológicas de la infección. En el presente estudio, entre niños que desarrollaron psicosis en la vida adulta, comparados con niños de control, no psiquiátricos, tratamos de examinar la contribución de la exposición prenatal al virus A y B de la gripe en el rendimiento cognitivo.MétodosLos individuos eran 111 casos (70 con esquizofrenia y 41 con psicosis afectivas) y 333 individuos de control, emparejados, seguidos desde el embarazo hasta los 7 años de edad a través del Collaborative Perinatal Project. Se administró la escala de inteligencia de Wechsler para niños (7 años) y la morbilidad psiquiátrica en la vida adulta se valoró mediante la revisión de las historias clínicas y se confirmó mediante un estudio de validación. A partir de los sueros prenatales archivados de las madres, obtenidos en el momento del parto, se efectuaron análisis y la infección por gripe se determinó mediante unos títulos de anticuerpos inmunoglobulina G (>percentil 75).ResultadosEntre los casos expuestos en el período prenatal al virus B de la gripe, en comparación con los no expuestos, se identificaron disminuciones significativas del cociente intelectual verbal y del subtest de información, al igual que reducciones no significativas similares en las puntuaciones del cociente intelectual de la escala total y en los subtest de vocabulario, comprensión, aritmética e historietas. La exposición fetal al virus B de la gripe no dio lugar a diferencias significativas del rendimiento cognitivo entre niños del grupo de control.ConclusionesEn conjunto, estos hallazgos sugieren que un factor genético y/o ambiental asociado con la psicosis aumenta la vulnerabilidad del cerebro fetal a los efectos particulares del virus B de la gripe, dando lugar a un peor rendimiento cognitivo, incluso antes del inicio de los síntomas.
    07/2010; 17(3):87-95. DOI:10.1016/j.psiq.2010.06.001
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Increasing epidemiological and experimental evidence implicates gestational infections as one important factor involved in the pathogenesis of several neuropsychiatric disorders. Corresponding preclinical model systems based upon maternal immune activation (MIA) by treatment of the pregnant female have been developed. These MIA animal model systems have been successfully used in basic and translational research approaches, contributing to the investigation of the underlying pathophysiological mechanisms at the molecular, cellular and behavioural levels. The present article focusses on the application of a specific MIA rodent paradigm, based upon treatment of the gestating dam with the viral mimic polyinosinic-poly cytidilic acid (Poly(I:C)), a synthetic analog of double-stranded RNA (dsRNA) which activates the Toll-like receptor 3 (TLR3) pathway. Important advantages and constraints of this animal model will be discussed, specifically in light of gestational infection as one vulnerability factor contributing to the complex aetiology of mood and psychotic disorders, which are likely the result of intricate multi-level gene x environment interactions. Improving our currently incomplete understanding of the molecular pathomechanistic principles underlying these disorders is a prerequisite for the development of alternative therapeutic approaches which are critically needed in light of the important drawbacks and limitations of currently available pharmacological treatment options regarding efficacy and side effects. The particular relevance of the Poly(I:C) MIA model for the discovery of novel drug targets for symptomatic and preventive therapeutic strategies in mood and psychotic disorders is highlighted in this review article.
    Pharmacology [?] Therapeutics 01/2015; 116. DOI:10.1016/j.pharmthera.2015.01.001 · 7.75 Impact Factor